Identification of novel biomarkers of prostate cancer through integrated analysis

BACKGROUND: The current methods adopted to screen for prostate cancer (PCa) can sometimes be misleading and inaccurate. Moreover, for advanced stages of PCa, the current effect of treatment is not satisfactory for some patients. Accordingly, we aimed to identify new biomarkers for the diagnosis and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Pu, Qian, Bei, Liu, Zijian, Wang, Decai, Lv, Fang, Xing, Yifei, Xiao, Yajun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421833/
https://www.ncbi.nlm.nih.gov/pubmed/34532249
http://dx.doi.org/10.21037/tau-21-401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421833/
https://www.ncbi.nlm.nih.gov/pubmed/34532249
http://dx.doi.org/10.21037/tau-21-401

Ejemplares similares